Malignant Melanoma in the 21st Century: The Emerging Molecular Landscape
Aleksandar Sekulić(The University of Texas MD Anderson Cancer Center), Svetomir N. Markovic(Mayo Clinic in Arizona), David C. Swanson(Mayo Clinic in Arizona), Susan D. Laman(Mayo Clinic in Arizona), Barbara A. Pockaj(Mayo Clinic in Arizona), Diva R. Salomão(Mayo Clinic in Arizona), Samuel Ejadi(Memorial Sloan Kettering Cancer Center), Richard G. Vile(Mayo Clinic), Mark R. Pittelkow(Mayo Clinic in Arizona), José S. Pulido(Wills Eye Hospital), Paul Haluska(Mayo Clinic in Arizona), Josep Genebriera De Lamo(Mayo Clinic), Arlo J. Miller(Mayo Clinic), Erik C. Thorland(Mayo Clinic in Arizona)
Cited by 148
Related Papers
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657
Erratum: Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|548
Update on erythrodermic cutaneous T-cell lymphoma: Report of the international society for cutaneous lymphomas
|Journal of the American Academy of Dermatology|2002|493